Mauro Galeazzi

Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide

Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz et al. · Arthritis & Rheumatism · 2002 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Systemic Lupus Erythematosus

Ricard Cervera, Munther A. Khamashta, Josep Font et al. · Medicine · 1993 · 982 citations

Life Sciences, Immunology, Internal Medicine +15

Morbidity and Mortality in Systemic Lupus Erythematosus During a 5-Year Period: A Multicenter Prospective Study of 1,000 Patients

Ricard Cervera, Munther A. Khamashta, Josep Font et al. · Medicine · 1999 · 432 citations

Medicine, Clinical Sciences, Internal Medicine +9

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial

Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz et al. · Arthritis & Rheumatism · 2004 · 387 citations · Full text

Medicine, Nephrology, Pharmacotherapy +14

miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis

Valerio Fulci, Gina Scappucci, Gian Domenico Sebastiani et al. · Human Immunology · 2009 · 287 citations

Life Sciences, Immunology, Molecular Medicine +12